CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer

Carcinogenesis

Volumn 35, Issue 5, 2014, Pages 983-991

  Wang, Yangmeng ^a   Ren, Fangli ^a   Wang, Yinyin ^a   Feng, Yarui ^a   Wang, Dianjun ^b   Jia, Baoqing ^b   Qiu, Ying ^a   Wang, Shiyan ^c   Yu, Jun ^c   Sung, Joseph J Y ^c   Xu, Jiake ^d   Zeps, Nikolajs ^d,e   Chang, Zhijie ^a  

^a State Key Laboratory of Biomembrane and Membrane Biotechnology School of Medicine National Engineering Laboratory for Anti tumor Therapeutics Tsinghua University ^*  (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e ST JOHN OF GOD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYL TERMINUS OF HSC70 INTERACTING PROTEIN; CYCLIN D1; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MYC PROTEIN; SYNAPTOTAGMIN I; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SEVERITY; DNA METHYLATION; DOWN REGULATION; GENE EXPRESSION; HCT116 CELL LINE; HUMAN; HUMAN CELL; METASTASIS; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; UBIQUITINATION;

AGED; AGED, 80 AND OVER; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HETEROGRAFTS; HUMANS; MALE; MICE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 84897970729     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt393     Document Type: Article

References (36)

1. Kerr, D. (2003) Clinical development of gene therapy for colorectal cancer. Nat. Rev. Cancer, 3, 615-622.
2. Vogelstein, B. et al. (2013) Cancer genome landscapes. Science, 339, 1546-1558.
3. Grivennikov, S. et al. (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell, 15, 103-113.
4. Ballinger, C.A. et al. (1999) Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol. Cell. Biol., 19, 4535-4545.
5. Meacham, G.C. et al. (2001) The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat. Cell Biol., 3, 100-105.
6. Connell, P. et al. (2001) The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat. Cell Biol., 3, 93-96.
7. Urushitani, M. et al. (2004) CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70. J. Neurochem., 90, 231-244.
8. Li, L. et al. (2004) CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription. Mol. Cell. Biol., 24, 856-864.
9. Shang, Y. et al. (2009) CHIP functions an E3 ubiquitin ligase of Runx1. Biochem. Biophys. Res. Commun., 386, 242-246.
10. Li, X. et al. (2008) CHIP promotes Runx2 degradation and negatively regulates osteoblast differentiation. J. Cell Biol., 181, 959-972.
11. Zhou, P. et al. (2003) ErbB2 degradation mediated by the co-chaperone protein CHIP. J. Biol. Chem., 278, 13829-13837.
12. Bento, C.F., et al. (2010) The chaperone-dependent ubiquitin ligase CHIP targets HIF-1alpha for degradation in the presence of methylglyoxal. PLoS One, 5, e15062.
13. Paul, I. et al. (2013) The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity. Oncogene, 32, 1284-1295.
14. Fan, M. et al. (2005) CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha. Mol. Endocrinol., 19, 2901-2914.
15. Jang, K.W. et al. (2011) The C-terminus of Hsp70-interacting protein promotes Met receptor degradation. J. Thorac. Oncol., 6, 679-687.
16. Kajiro, M. et al. (2009) The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways. Nat. Cell Biol., 11, 312-319.
17. Wang, S. et al. (2013) CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer. Gut, 62, 496-508.
18. Wang, F. et al. (2008) Varp interacts with Rab38 and functions as its potential effector. Biochem. Biophys. Res. Commun., 372, 162-167.
19. Su, F. et al. (2012) Protein tyrosine phosphatase Meg2 dephosphorylates signal transducer and activator of transcription 3 and suppresses tumor growth in breast cancer. Breast Cancer Res., 14, R38.
20. Franken, N.A. et al. (2006) Clonogenic assay of cells in vitro. Nat. Protoc., 1, 2315-2319.
21. Liang, C.C. et al. (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc., 2, 329-333.
22. Huang, M.C. et al. (2006) C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells. Oncogene, 25, 3267-3276.
23. Sakamoto, K. et al. (2009) Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth. Clin. Cancer Res., 15, 2248-2258.
24. Hatakeyama, S. (2011) TRIM proteins and cancer. Nat. Rev. Cancer, 11, 792-804.
25. Welcker, M. et al. (2008) FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer, 8, 83-93.
26. Cheng, Y. et al. (2012) Role of the ubiquitin ligase Fbw7 in cancer progression. Cancer Metastasis Rev., 31, 75-87.
27. Zhao, D. et al. (2010) The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation. Cancer Res., 70, 4728-4738.
28. Wu, W. et al. (2008) The ubiquitin E3 ligase activity of BRCA1 and its biological functions. Cell Div., 3, 1.
29. Baer, R. et al. (2002) The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity. Curr. Opin. Genet. Dev., 12, 86-91.
30. Khacho, M. et al. (2009) Subcellular dynamics of the VHL tumor suppressor: on the move for HIF degradation. Future Oncol., 5, 85-95.
31. Haase, V.H. (2009) The VHL tumor suppressor: master regulator of HIF. Curr. Pharm. Des., 15, 3895-3903.
32. Chen, B.B. et al. (2012) F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation. Blood, 119, 3132-3141.
33. Chen, B.B. et al. (2012) F-box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resulting in cell cycle arrest. Oncogene, 31, 2566-2579.
34. Pei, X.H. et al. (2011) Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis. Cancer Res., 71, 2969-2977.
35. Hanahan, D. et al. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
36. Sakamoto, K. et al. (2010) Targeting NF-kappaB for colorectal cancer. Expert Opin. Ther. Targets, 14, 593-601.